You can find the annual or quarterly income statement of Can Fite Biopharma Ltd here for insights into the performance and operational efficiency of Can Fite Biopharma Ltd.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2019Q4

FY2019Q3

Total revenue

-21.32%155.00K

-3.92%196.00K

-4.39%196.00K

-3.43%197.00K

-18.73%204.00K

-18.40%204.00K

38.51%205.00K

36.00%204.00K

18.96%251.00K

--250.00K

--148.00K

-21.88%150.00K

-81.68%211.00K

--192.00K

--1.15M

Revenue

-21.32%155.00K

-3.92%196.00K

-4.39%196.00K

-3.43%197.00K

-18.73%204.00K

-18.40%204.00K

38.51%205.00K

36.00%204.00K

18.96%251.00K

--250.00K

--148.00K

-21.88%150.00K

-81.68%211.00K

--192.00K

--1.15M

Operating expenses

-39.36%1.99M

-25.78%2.06M

-12.93%1.98M

12.93%2.91M

-22.50%3.28M

-26.16%2.78M

-32.78%2.27M

11.04%2.58M

14.29%4.23M

39.81%3.76M

--3.38M

--2.32M

-22.90%3.70M

-31.78%2.69M

--4.80M

--3.94M

R&D expenses

53.39%1.27M

75.30%1.30M

212.65%2.57M

12.33%847.00K

-26.97%826.00K

-9.85%741.00K

-6.16%822.00K

-25.79%754.00K

40.15%1.13M

19.30%822.00K

--876.00K

--1.02M

-4.27%807.00K

-22.32%689.00K

--843.00K

--887.00K

Operating profit

40.51%-1.83M

27.52%-1.86M

13.82%-1.78M

-14.43%-2.71M

23.46%-3.08M

26.70%-2.57M

33.93%-2.07M

-9.17%-2.37M

-13.37%-4.03M

-41.59%-3.51M

---3.13M

---2.17M

22.95%-3.55M

11.18%-2.48M

---4.61M

---2.79M

Net non-operating interest income (expenses)

Non-operating interest income

184.38%182.00K

134.09%103.00K

--114.00K

--162.00K

--64.00K

-60.00%44.00K

----

--110.00K

----

--293.00K

----

Non-operating interest expense

----

40.70%121.00K

--64.00K

12.50%90.00K

----

--86.00K

----

-53.76%80.00K

-38.85%96.00K

--173.00K

--157.00K

Income before tax

45.28%-1.65M

30.33%-1.76M

23.78%-1.67M

-4.77%-2.55M

26.69%-3.02M

25.62%-2.53M

31.94%-2.19M

-29.61%-2.43M

-13.35%-4.12M

-32.04%-3.40M

---3.22M

---1.88M

24.06%-3.63M

12.65%-2.58M

---4.78M

---2.95M

Income tax

----

--0.00

----

--0.00

----

Income after tax

45.28%-1.65M

30.33%-1.76M

23.78%-1.67M

-4.77%-2.55M

26.69%-3.02M

25.62%-2.53M

31.94%-2.19M

-29.61%-2.43M

-13.35%-4.12M

-32.04%-3.40M

---3.22M

---1.88M

24.06%-3.63M

12.65%-2.58M

---4.78M

---2.95M

Net income from continuous operations

45.28%-1.65M

30.33%-1.76M

23.78%-1.67M

-4.77%-2.55M

26.69%-3.02M

25.62%-2.53M

31.94%-2.19M

-29.61%-2.43M

-13.35%-4.12M

-32.04%-3.40M

---3.22M

---1.88M

24.06%-3.63M

12.65%-2.58M

---4.78M

---2.95M

Net income attributable to controlling interests

45.28%-1.65M

30.33%-1.76M

23.78%-1.67M

-4.77%-2.55M

54.99%-3.02M

25.62%-2.53M

31.94%-2.19M

-29.61%-2.43M

-84.64%-6.71M

-32.04%-3.40M

---3.22M

---1.88M

24.06%-3.63M

12.65%-2.58M

---4.78M

---2.95M

Preferred share dividend

----

--2.59M

--0.00

Net income attributable to common shareholders

45.28%-1.65M

30.33%-1.76M

23.78%-1.67M

-4.77%-2.55M

54.99%-3.02M

25.62%-2.53M

31.94%-2.19M

-29.61%-2.43M

-84.64%-6.71M

-32.04%-3.40M

---3.22M

---1.88M

24.06%-3.63M

12.65%-2.58M

---4.78M

---2.95M

Basic earnings per share

70.00%0.00

53.55%0.00

49.44%0.00

27.52%0.00

63.33%0.00

50.08%0.00

56.89%0.00

23.20%0.00

-28.70%-0.01

-10.89%-0.01

---0.01

--0.00

80.29%-0.01

80.11%-0.01

---0.04

---0.03

Diluted earnings per share

70.00%0.00

53.55%0.00

49.44%0.00

27.52%0.00

63.33%0.00

50.08%0.00

56.89%0.00

23.20%0.00

-28.70%-0.01

-10.89%-0.01

---0.01

--0.00

80.29%-0.01

80.11%-0.01

---0.04

---0.03

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

